Abiomed
ABMD
#1119
Rank
ยฃ13.29 B
Marketcap
ยฃ294.89
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : ยฃ0.12 Billion

According to Abiomed's latest financial reports the company's total liabilities are ยฃ0.12 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abiomed - Total liabilities on balance sheet (from 2013 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-03-31ยฃ0.12 B8.05%
2021-03-31ยฃ0.11 B-1.84%
2020-03-31ยฃ0.12 B35.54%
2019-03-31ยฃ90.04 M30.31%
2018-03-31ยฃ69.1 M-12.32%
2017-03-31ยฃ78.81 M105.38%
2016-03-31ยฃ38.37 M21.4%
2015-03-31ยฃ31.6 M41.97%
2014-03-31ยฃ22.26 M2.83%
2013-03-31ยฃ21.65 M25.41%
2012-03-31ยฃ17.26 M3.37%
2011-03-31ยฃ16.7 M17.32%
2010-03-31ยฃ14.23 M2.23%
2009-03-31ยฃ13.92 M13.06%
2008-03-31ยฃ12.31 M71.58%
2007-03-31ยฃ7.17 M37.84%
2006-03-31ยฃ5.2 M101.55%
2005-03-31ยฃ2.58 M-1.29%
2004-03-31ยฃ2.61 M-33.95%
2003-03-31ยฃ3.96 M-44.62%
2002-03-31ยฃ7.15 M8.48%
2001-03-31ยฃ6.59 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ2.32 B 1,816.71%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ12.76 B 10,425.21%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.11 B-4.28%๐Ÿ‡บ๐Ÿ‡ธ USA